HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyridinesDisopyramide
Chemical structure of CAS 3737-09-5

Disopyramide

In Stock•Starting at $31 for 250 mg•Purity ≥ 99%
CAS No.3737-09-5
MDL No.MFCD00057366
MFC21H29N3O
MW339.50
InChI KeyUVTNFZQICZKOEM-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
250 mg99%$31In Stock
1 g99%$72In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Disopyramide is a monocarboxylic acid amide with a butanamide backbone substituted by a diisopropylamino group at position 4, a phenyl group at position 2, and a pyridin-2-yl group at position 2. It functions as an anti-arrhythmia drug and is classified as a tertiary amino compound and a member of pyridines.

CAS No.3737-09-5
Product NameDisopyramide

Biological Targets

SCN1A·SCN5A·SCN4A·SCN7A·SCN2A·

Associated Conditions

Ventricular arrhythmia·cardiac arrhythmia·atrial fibrillation·heart failure
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.

Biochemical and biophysical research communications • Vol. 280, Issue 5 • 2001
PMID: 11162661DOI: 10.1006/bbrc.2001.4269

Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.

European journal of pharmacology • Vol. 413, Issue 1 • 2001
PMID: 11173068DOI: 10.1016/s0014-2999(01)00740-3

Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.

Medical science monitor : international medical journal of experimental and clinical research • Vol. 7, Issue 1 • 2001
PMID: 11208496

Influence of the light schedule on the toxic interaction between propranolol and disopyramide in chick embryos.

Biological & pharmaceutical bulletin • Vol. 24, Issue 4 • 2001
PMID: 11305609DOI: 10.1248/bpb.24.429

Documentation

Similar Products